Alectinib induced CNS radiation necrosis in an ALK+NSCLC patient with a remote (7 years) history of brain radiation.
Ou, Sai-Hong Ignatius
Alectinib induced CNS radiation necrosis in an ALK+NSCLC patient with a remote (7 years) history of brain radiation. [electronic resource] - Lung cancer (Amsterdam, Netherlands) 06 2016 - 15-8 p. digital
Publication Type: Case Reports; Journal Article
1872-8332
10.1016/j.lungcan.2016.03.008 doi
Adenocarcinoma--metabolism
Adenocarcinoma of Lung
Anaplastic Lymphoma Kinase
Brain--drug effects
Brain Neoplasms--drug therapy
Carbazoles--adverse effects
Crizotinib
Disease Progression
Humans
Lung Neoplasms--metabolism
Male
Middle Aged
Necrosis--chemically induced
Piperidines--adverse effects
Protein Kinase Inhibitors--therapeutic use
Pyrazoles--pharmacology
Pyridines--pharmacology
Radiation Injuries--chemically induced
Receptor Protein-Tyrosine Kinases--antagonists & inhibitors
Treatment Outcome
Alectinib induced CNS radiation necrosis in an ALK+NSCLC patient with a remote (7 years) history of brain radiation. [electronic resource] - Lung cancer (Amsterdam, Netherlands) 06 2016 - 15-8 p. digital
Publication Type: Case Reports; Journal Article
1872-8332
10.1016/j.lungcan.2016.03.008 doi
Adenocarcinoma--metabolism
Adenocarcinoma of Lung
Anaplastic Lymphoma Kinase
Brain--drug effects
Brain Neoplasms--drug therapy
Carbazoles--adverse effects
Crizotinib
Disease Progression
Humans
Lung Neoplasms--metabolism
Male
Middle Aged
Necrosis--chemically induced
Piperidines--adverse effects
Protein Kinase Inhibitors--therapeutic use
Pyrazoles--pharmacology
Pyridines--pharmacology
Radiation Injuries--chemically induced
Receptor Protein-Tyrosine Kinases--antagonists & inhibitors
Treatment Outcome